Page not found

Integrative Physiology & Pharmacology Ph.D. Program at Wake Forest University


Wake Forest University Graduate School » Integrative Physiology & Pharmacology Ph.D. Program

Anthony Atala, M.D.

Anthony Atala, M.D.
Anthony Atala, MD, is the Director of the Wake Forest Institute for Regenerative Medicine, and the W.H. Boyce Professor and Chair of the Department of Urology at Wake Forest University.  Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine.  His current work focuses on growing new human cells, tissues and organs.   Dr. Atala works with several journals and serves in various roles, including Editor-in-Chief of Stem Cells- Translational Medicine, Current Stem Cell Research and Therapy, and Therapeutic Advances in Urology; as Associate Editor of Tissue Engineering and Regenerative Medicine, Rejuvenation Research, and Gene Therapy and Regulation; as Executive Board Member or Section Editor of the International Journal of Artificial Organs, Organogenesis, and Current Urology Reports; and as Editorial Board member of Expert Opinion on Biological Therapy, Biomedical Materials, Journal of Tissue Science and Engineering, 3D Printing and Additive Manufacturing, Technology, the Journal of Urology, Recent Patents on Regenerative Medicine, BioMed Central-Urology, Urology, and Current Transplantation Reports.   Dr. Atala is a recipient of many awards, including the US Congress funded Christopher Columbus Foundation Award, bestowed on a living American who is currently working on a discovery that will significantly affect society,  the World Technology Award in Health and Medicine, presented to individuals achieving significant and lasting progress, the Samuel D. Gross Prize, awarded every 5 years to a national leading surgical researcher by the Philadelphia Academy of Surgery, the Barringer Medal from the American Association of Genitourinary Surgeons  for distinguished accomplishments, the Gold Cystoscope award from the American Urological Association for advances in the field, the Ramon Guiteras Award for pioneering research in regenerative medicine and outstanding contributions as a scholar and teacher, the Innovation Award from the Society of Manufacturing Engineers for the creation of synthetic organs, and the Rocovich Gold Medal, awarded to a distinguished scientist who has made a major impact on science toward the understanding of human disease. In 2011 he was elected to the Institute of Medicine of the National Academy of Sciences.  Dr. Atala was elected to the Royal Academy for the Encouragement of the Arts in 2012, and to the National Academy of Inventors as a Charter Fellow in 2013.  Dr. Atala's team received the Edison Science/Medical Award in 2013.   Dr. Atala’s work has been described in the lay press. In 2003 he was named by Scientific American as a Medical Treatments Leader of the Year for his contributions to the fields of cell, tissue and organ regeneration.  Dr. Atala’s work was listed as Time Magazine’s top 10 medical breakthroughs of the year, and as Discover Magazine`s Number 1 Top Science Story of the Year in the field of medicine in 2007. In 2009 Dr. Atala was featured in U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century, and his work in 2010 was listed by Smithsonian Magazine as one of 40 things to know about the next 40 years. Dr. Atala’ work was listed in the Huffington post as one of 18 great ideas of 2011, in Time Magazine as one of the top 5 medical breakthroughs of the year in 2011, by the American Association of Retired Persons as one of the 50 influential people who will make life better in 2012, and by Time Magazine as one of 5 discoveries that will change the future of organ transplants in 2013.   Dr. Atala has led or served several national professional and government committees, including the National Institutes of Health working group on Cells and Developmental Biology, the National Institutes of Health Bioengineering Consortium, and the National Cancer Institute’s Advisory Board. Dr. Atala heads a team of over 300 physicians and researchers.  Over ten applications of technologies developed in Dr. Atala's laboratory have been used clinically. He is the editor of twelve books, including Essentials of Stem Cell Biology, Principles of Regenerative Medicine, Foundations of Regenerative Medicine, Methods of Tissue Engineering, and Minimally Invasive Urology. He has published more than 400 journal articles and has applied for or received over 200 national and international patents.

 

Atala A, Lanza RP, eds. In: Handbook of stem cells. Oxford: Elsevier/Academic Press;2013: .


Xu T, Zhao W, Zhu JM, Albanna MZ, Yoo JJ, Atala A. Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology. Biomaterials. 2013;34(1):130-139.


Murphy SV, Skardal A, Atala A. Evaluation of hydrogels for bio-printing applications. J Biomed Mater Res A. 2013;101(1):272-284.

Sittadjody S, Saul JM, Joo S, Yoo JJ, Atala A, Opara EC. Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins. Biomaterials. 2013;34(10):2412-2420.

Stanasel I, Atala A, Hemal A. Robotic assisted ureteral reimplantation: current status. Curr Urol Rep. 2013;14(1):32-36.

Arenas-Herrera JE, Ko IK, Atala A, Yoo JJ. Decellularization for whole organ bioengineering. Biomed Mater. 2013;8(1):014106.

Orabi H, AbouShwareb T, Zhang Y, Yoo JJ, Atala A. Cell-seeded tubularized scaffolds for reconstruction of long urethral defects: a preclinical study. Eur Urol. 2013;63(3):531-538.

Hwang CM, Ay B, Kaplan DL, Rubin JP, Marra KG, Atala A, Yoo JJ, Lee SJ.Assessments of injectable alginate particle-embedded fibrin hydrogels for soft tissue reconstruction. Biomed Mater. 2013;8(1):014105.


Lang R, Liu G, Shi Y, Bharadwaj S, Leng X, Zhou X, Liu H, Atala A, Zhang Y. Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours. PLoS One. 2013;8(1):e53980.


Murphy SV, Atala A. Amniotic fluid and placental membranes: unexpected sources of highly multipotent cells. Semin Reprod Med. 2013;31(1):62-68.



Liu G, Pareta RA, Wu R, Shi Y, Zhou X, Liu H, Deng C, Sun X, Atala A, Opara EC, Zhang Y. Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors. Biomaterials. 2013;34(4):1311-1326.

Moschidou D, Mukherjee S, Blundell MP, Jones GN, Atala AJ, Thrasher AJ, Fisk NM, De Coppi P, Guillot PV. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics. Stem Cells Dev. 2013;22(3):444-458.

Atala A. Stem cell advances and challenges [editorial]. Curr Stem Cell Res Ther. 2013;8(1):1.

Kwatra S, Powers A, Atala A, Yosipovitch G, Kaushik S, McLean T. Successful treatment of ulcerated infantile hemangioma associated with PELVIS syndrome using oral propanolol [abstract]. J Am Acad Dermatol. 2013;68(4 Suppl 1):AB178.


Zhou Y, Mack DL, Williams JK, Mirmalek-Sani SH, Moorefield E, Chun SY, Wang J, Lorenzetti D, Furth M, Atala A, Soker S. Genetic modification of primate amniotic fluid-derived stem cells produces pancreatic progenitor cells in vitro. Cells Tissues Organs. 2013;197(4):269-282.

Xu T, Binder KW, Albanna MZ, Dice D, Zhao W, Yoo JJ, Atala A. Hybrid printing of mechanically and biologically improved constructs for cartilage tissue engineering applications. Biofabrication. 2013;5(1):015001.


Orlando G, Bendala JD, Shupe T, Bergman C, Bitar KN, Booth C, Carbone M, Koch KL, Lerut JP, Neuberger JM, Petersen B, Ricordi C, Atala A, Stratta RJ, Soker S.Cell and organ bioengineering technology as applied to gastrointestinal diseases. Gut. 2013;62(5):774-786.

Atala A. Organ regenerative engineering: cell sources, material considerations, and strategies In: Laurencin CT, Khan Y, eds. Regenerative engineering. Boca Raton (FL): Taylor & Francis;2013: .

Keys T, King NMP, Atala A. Faith in science: professional and public discourse on regenerative medicine In: Hyde MJ, Herrick JA, eds. After the genome: a language for our biotechnological future. Waco (TX): Baylor University Press;2013: 11-40.

Atala A. Foreward In: dos Santos Goldenberg RC, de Carvalho CC, eds. Resident stem cells and regenerative therapy. Oxford: Academic Press;2013: xi.

Murphy SV, Atala A. Amniotic fluid stem cells In: Cetrulo K, Cetrulo CL Jr, Taghizadeh RR, eds. Perinatal stem cells. 2nd ed. Hoboken (NJ): Wiley-Blackwell;2013: 1-13.

Mirmalek-Sani SH, Orlando G, McQuilling JP, Pareta R, Mack DL, Salvatori M, Farney AC, Stratta RJ, Atala A, Opara EC, Soker S. Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering. Biomaterials. 2013;34(22):5488-5495.

Horst M, Madduri S, Gobet R, Sulser T, Milleret V, Hall H, Atala A, Eberli D.Engineering functional bladder tissues. J Tissue Eng Regen Med. 2013;7(7):515-522.

Kuo C-J, Mokhtari S, Soland M, Soker S, Yoo J, Owen J, Knovich MA, Atala A, Almeida-Porada G, Porada C. Amniotic fluid stem cells for the treatment of hemophilia A [abstract]. Mol Ther. 2013;21(Suppl 1):S96-S97.


Maghsoudlou P, Georgiades F, Tyraskis A, Totonelli G, Loukogeorgakis SP, Orlando G, Shangaris P, Lange P, Delalande JM, Burns AJ, Cenedese A, Sebire NJ, Turmaine M, Guest BN, Alcorn JF, Atala A, Birchall MA, Elliott MJ,. Preservation of micro-architecture and angiogenic potential in a pulmonary acellular matrix obtained using intermittent intra-tracheal flow of detergent enzymatic treatment. Biomaterials. 2013;34(28):6638-6648.

Orlando G, Soker S, Stratta RJ, Atala A. Will regenerative medicine replace transplantation?. Cold Spring Harb Perspect Med. 2013;3(8):a015693.

Zhao W, Ju YM, Christ G, Atala A, Yoo JJ, Lee SJ. Diaphragmatic muscle reconstruction with an aligned electrospun poly(epsilon-caprolactone)/collagen hybrid scaffold. Biomaterials. 2013;34(33):8235-8240.

Zhang Y, Atala A. Urothelial cell culture. Methods Mol Biol. 2013;1037():27-43.

Atala A, Deng M, Khan Y. Organ regenerative engineering: cell sources, considerations, and strategies In: Laurencin CT, Khan Y, eds. Regenerative engineering. Boca Raton (FL): CRC Press;2013: 183-218.

Ko IK, Ju YM, Chen T, Atala A, Yoo JJ, Lee SJ. Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration. FASEB J. 2012;26(1):158-168.

Jordan JE, Williams JK, Lee S-J, Raghavan D, Atala A, Yoo JJ. Bioengineered self-seeding heart valves. J Thorac Cardiovasc Surg. 2012;143(1):201-208.

Atala A. Regenerative medicine strategies. J Pediatr Surg. 2012;47(1):17-28.

Joo S, Ko IK, Atala A, Yoo JJ, Lee SJ. Amniotic fluid-derived stem cells in regenerative medicine research. Arch Pharm Res. 2012;35(2):271-280.

Sohn MY, Seo JM, Cho HJ, Suh JS, Seong WJ, Park IS, Atala A, Yoo JJ, Shon YH.Effective in vitro expansion of amniotic fluid-derived stem cells in serum free medium. Tissue Eng Regen Med. 2012;9(1):A48-A54.

Atala A. Regenerative medicine in urology: stem cells, tissue engineering, and cloning In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh urology, vol 1. 10th ed. Philadelphia: Elsevier Saunders;2012: 568-588.

Krane LS, Atala A. Tissue engineering, stem cells, and cell therapy in nephrology In: Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM, eds. Brenner & Rector's the kidney, vol 2. 9th ed. Philadelphia: Elsevier Saunders;2012: 2851-2868.


Mhashilkar A, Atala A. Effective bio-economic approaches for stem cell therapy and regenerative medicine [editorial]. Curr Stem Cell Res Ther. 2012;7(1):1.

Totonelli G, Maghsoudlou P, Garriboli M, Riegler J, Orlando G, Burns AJ, Sebire NJ, Smith VV, Fishman JM, Ghionzoli M, Turmaine M, Birchall MA, Atala A, Soker S, Lythgoe MF, Seifalian A, Pierro A, Eaton S, De Coppi P. A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials. 2012;33(12):3401-3410.

Orlando G, Mirmalek-Sani SH, Sullivan DC, Farney A, Iskandar S, Abouschwareb T [sic] [Aboushwareb T], Arenas-Herrera J, Ko IK, Agcaoili S, Yoo JJ, Atala A, Stratta RJ, Soker S. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering [abstract]. Am J Transplant. 2012;12(Suppl 2):94.

Skardal A, Smith L, Bharadwaj S, Atala A, Soker S, Zhang Y. Tissue specific synthetic ECM hydrogels for 3-D in vitro maintenance of hepatocyte function. Biomaterials. 2012;33(18):4565-4575.

Orlando G, Wood KJ, De Coppi P, Baptista PM, Binder KW, Bitar KN, Breuer C, Burnett L, Christ G, Farney A, Figliuzzi M, Holmes JH IV, Koch K, Macchiarini P, Mirmalek Sani S-H, Opara E, Remuzzi A, Rogers J, Saul JM, Seliktar D,.Regenerative medicine as applied to general surgery. Ann Surg. 2012;255(5):867-880.

Atala A, ed. In: Progenitor and stem cell technologies and therapies. Cambridge (UK): Woodhead Publishing;2012: .

Atala A. Basic principles of amniotic and placental stem cells In: Atala A, ed. Progenitor and stem cell technologies and therapies. Cambridge (UK): Woodhead Publishing;2012: 64-76.

Atala A. Genitourinary progenitor and stem cell biology and therapy In: Atala A, ed. Progenitor and stem cell technologies and therapies. Cambridge (UK): Woodhead Publishing;2012: 501-525.

Rodrigues MT, Lee B-K, Lee SJ, Gomes ME, Reis RL, Atala A, Yoo JJ. The effect of differentiation stage of amniotic fluid stem cells on bone regeneration. Biomaterials. 2012;33(26):6069-6078.

Atala A. Tissue engineering of reproductive tissues and organs. Fertil Steril. 2012;98(1):21-29.

Atesok K, Matsumoto T, Karlsson J, Asahara T, Atala A, Doral MN, Verdonk R, Li R, Schemitsch E. An emerging cell-based strategy in orthopaedics: endothelial progenitor cells. Knee Surg Traumatol Arthrosc. 2012;20(7):1366-1377.




Zhao Q, Lu B, George SK, Yoo JJ, Atala A. Safeguarding pluripotent stem cells for cell therapy with a non-viral, non-integrating episomal suicide construct. Biomaterials. 2012;33(29):7261-7271.

Orlando G, Farney AC, Iskandar SS, Mirmalek-Sani S-H, Sullivan DC, Moran E, AbouShwareb T, De Coppi P, Wood KJ, Stratta RJ, Atala A, Yoo JJ, Soker S.Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg. 2012;256(2):363-370.

Rota C, Imberti B, Pozzobon M, Piccoli M, De Coppi P, Atala A, Gagliardini E, Xinaris C, Benedetti V, Fabricio AS, Squarcina E, Abbate M, Benigni A, Remuzzi G, Morigi M. Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev. 2012;21(11):1911-1923.

Sullivan DC, Mirmalek-Sani SH, Deegan DB, Baptista PM, Aboushwareb T, Atala A, Yoo JJ. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials. 2012;33(31):7756-7764.

Guimaraes-Souza NK, Yamaleyeva LM, AbouShwareb T, Atala A, Yoo JJ. In vitro reconstitution of human kidney structures for renal cell therapy. Nephrol Dial Transplant. 2012;27(8):3082-3090.

Tillman BW, Yazdani SK, Neff LP, Corriere MA, Christ GJ, Soker S, Atala A, Geary RL, Yoo JJ. Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture. J Vasc Surg. 2012;56(3):783-793.

Agcaoili SM, Aboushwareb T, Jackson JD, Atala A, Yoo JJ. Repopulation of primary renal cells for whole organ engineering [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):126.

Albanna MZ, Murphy S, Zhao W, El-Amin IB, Tan J, Jackson JD, Atala A, Yoo JJ. In situ bioprinting of autologous skin cells accelerates skin regeneration [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):94.

Bharadwaj S, Liu GH, Wu S, Andersson K-E, Atala A, Zhang Y. Biological characterization of human urine-derived stem cells from the upper urinary tract for potential use in bladder regeneration in patients with end-stage bladder disease [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):132.

George SK, Gyabaah K, Abolbashari M, Kim C, Jackson JD, Aboushwareb T, Atala A, Yoo JJ. The feasibility of using autologous renal cells from diseased kidneys for the treatment of renal failure [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):127.

Gyabaah K, Aboushwareb T, Guimaraes Souza N, Yamaleyeva L, Varner A, Wang HJ, Atala A, Yoo JJ. Controlled regulation of erythropoietin by primary cultured renal cells for renal failure induced anemia. J Urol. 2012;188(5):2000-2006.

Hwang CM, Atala A, Yoo J, Jackson J, Lee SJ. A porous injectable hydrogel system for soft tissue regeneration [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):158.

Joo S, Helms A, Sivanandane S, Jackson JD, Soker S, Lee SJ, Atala A, Opara E, Yoo JJ. Development of ovarian follicle-like structures [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):131.

Kang SB, Olson JL, Atala A, Yoo JJ. Functional recovery of completely denervated muscle: implications for innervation of tissue-engineered muscle. Tissue Eng Part A. 2012;18(17-18):1912-1920.

Kim J, Hwang A, Khouri R, Andersson K-E, Lee SJ, Jackson J, Atala A, Yoo J.Down-regulation of cellular metabolism improves cell survival under hypoxic conditions [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):275.

Ko IK, Ju YM, DeLeon J, Atala A, Yoo JJ, Lee SJ. Combined systemic and local delivery of stem cell recruitment for in situ tissue regeneration [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):116.

Ko IK, Mirmalek-Sani S-H, Aboushwareb T, Atala A, Soker S, Yoo J. Re-endothelialization of acellular kidney scaffolds for whole organ engineering [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):128.

Lee BK, Ju YM, Cho JG, Jackson JD, Lee SJ, Atala A, Yoo JJ. End-to-side neurorrhaphy using an electrospun PCL/collagen nerve conduit for complex peripheral motor nerve regeneration. Biomaterials. 2012;33(35):9027-9036.

Mirmalek-Sani SH, Deegan DB, Sullivan DC, Ko I, George SK, Jackson JD, Aboushwareb TA, Atala A, Yoo J. Optimizing decellularization of porcine kidneys for whole organ bioengineering [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):172.

Orlando G, Wang Z, Booth C, Ross C, Totonelli G, De Coppi P, Marini F, Atala A, Stratta RJ, Soker S. Production and characterization of human renal and ileal ECM scaffols: the ideal platform for renal and intestinal bioengineering investigations [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):127-128.

Shi YA, Liu GH, Bharadwaj S, Markert C, Atala A, Zhang Y. Urine derived stem cells with high telomerase activity: an optimized cell source for regenerative medicine in urology [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):132.

Sivanandane S, Saul J, Joo S, Pareta R, Arenas J, Marshall N, Yoo J, Atala A, Opara E. Encapsulated ovarian endocrine cells produced sustained levels of steroid hormones in vivo [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):410.

Agcaoili SM, Aboushwareb T, Jackson JD, Yoo JJ, Atala A. Repopulation of primary renal cells for whole organ engineering [abstract]. J Am Coll Surg. 2012;215(3 Suppl):S142-S143.

Albanna MZ, Murphy S, Zhao W, El-Amin IB, Tan J, Dice DD, Kang H-W, Jackson JD, Yoo JJ, Atala A. In situ bioprinting of skin for reconstruction [abstract]. J Am Coll Surg. 2012;215(3 Suppl):S87.


Joo S, Sivanandane S, Opara EC, Jackson JD, Yoo JJ, Atala A. In vitro generation of three-dimensional functional ovarian structures [abstract]. J Am Coll Surg. 2012;215(3 Suppl):S65.

Lee B, JU YM, Cho J, Lee SJ, Jackson JD, Yoo JJ, Atala A. Use of a neighboring uninjured nerve for restoration of tissue function [abstract]. J Am Coll Surg. 2012;215(3 Suppl):S145.

Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, Nowakowska B, Phoolchund A, Lay K, Ramasamy TS, Cananzi M, Nettersheim D, Sullivan M, Frost J, Moore G, Vermeesch JR, Fisk NM, Thrasher AJ,. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther. 2012;20(10):1953-1967.

Atala A, Kasper FK, Mikos AG. Engineering complex tissues. Sci Transl Med. 2012;4(160):160rv12.

Mhashilkar AM, Atala A. Advent and maturation of regenerative medicine. Curr Stem Cell Res Ther. 2012;7(6):430-445.

Murphy SV, Lim R, Heraud P, Cholewa M, Le Gros M, de Jonge MD, Howard DL, Paterson D, McDonald C, Atala A, Jenkin G, Wallace EM. Human amnion epithelial cells induced to express functional cystic fibrosis transmembrane conductance regulator. PLoS One. 2012;7(9):e46533.

Skardal A, Mack D, Kapetanovic E, Atala A, Jackson JD, Yoo J, Soker S.Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds. Stem Cells Transl Med. 2012;1(11):792-802.

Kim BS, Chun SY, Lee JK, Lim HJ, Bae JS, Chung HY, Atala A, Soker S, Yoo JJ, Kwon TG. Human amniotic fluid stem cell injection therapy for urethral sphincter regeneration in an animal model. BMC Med. 2012;10():94.

Wang HJ, Varner A, Aboushwareb T, Atala A, Yoo JJ. Ischemia/reperfusion-induced renal failure in rats as a model for evaluating cell therapies. Ren Fail. 2012;34(10):1324-1332.

Yamaleyeva LM, Guimaraes-Souza NK, Krane LS, Agcaoili S, Gyabaah K, Atala A, Aboushwareb T, Yoo JJ. Cell therapy with human renal cell cultures containing erythropoietin-positive cells improves chronic kidney injury. Stem Cells Transl Med. 2012;1(5):373-383.

Rodrigues MT, Lee SJ, Gomes ME, Reis RL, Atala A, Yoo JJ. Amniotic fluid-derived stem cells as a cell source for bone tissue engineering. Tissue Eng Part A. 2012;18(23-24):2518-2527.

Atala A. A new era in stem cells translational medicine [editorial]. Stem Cells Transl Med. 2012;1(1):1-2.

Eberli D, Aboushwareb T, Soker S, Yoo JJ, Atala A. Muscle precursor cells for the restoration of irreversibly damaged sphincter function. Cell Transplant. 2012;21(9):2089-2098.

Kim J, Joo S, Ko IK, Atala A, Yoo JJ, Lee SJ. Smart biomaterial scaffold for in situ tissue regeneration In: Ramalingam M, Ramakrishna S, Best S, eds. Biomaterials and stem cells in regenerative medicine. Boca Raton (FL): Taylor & Francis;2012: 79-100.

Yoo JJ, Atala A, Christ GJ, inventors; Wake Forest University Health Sciences, assignee. Bioreactor system and method of enhancing functionality of muscle culture in vitro. European patent office EP 1,902,127. 2012 Aug 29. 2012;():.

 

Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine. His current work focuses on growing new human cells, tissues and organs.